Simon Gayther, PhD
Project Title: “Identifying molecular targets for prevention of P53 mutant serous tubal intraepithelial carcinomas”
Dr. Gayther is the Barth Family Chair in Cancer Genetics, Director of Molecular Epidemiology, Department of Biomedical Sciences, and Co-Director of the Center for Bioinformatics and Functional Genomics at Cedars-Sinai Medical Center, Los Angeles.
DIPANJAN CHOWDHURY, PhD & KEVIN ELIAS, MD
Project Title: “Monitoring and detection of ovarian cancer using serum microRNA signatures in high-risk families”
Dr. Chowdhury is a Professor of Medicine at Harvard Medical School and Chief of the Division of Radiation and Genome Stability in the Department of Radiation Oncology at the Dana-Farber Cancer Institute. Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women's Hospital.
Ie-Ming Shih, MD, PhD
Project Title: “PapDREAMing for the detection of premalignant ovarian cancer”
Dr. Shih is a Richard W. TeLinde Distinguished Professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine and a board-certified attending pathologist in the Division of Gynecologic Pathology at the Johns Hopkins Hospital.
Andrew K. Godwin, PhD, Steven Soper, PhD, & Claudio Soto, PhD
Project Title: “Developing a misfolded p53 aggregation assay to interrogate disease-specific exosomes captured using a microfluidic device for the early detection of epithelial ovarian cancer”
Dr. Godwin is the Chancellors Distinguished Chair in Biomedical Sciences, Endowed Professor, and Director of Molecular Oncology, Pathology and Laboratory Medicine at The University of Kansas Medical Center. In the fall of 2019, Dr. Godwin was named the recipient of the Dolph Simons Award in the Biomedical Sciences. Dr. Soper is a Foundation Distinguished Professor at The University of Kansas and holds joint appointments in the Departments of Chemistry and Mechanical Engineering. Dr. Soto is the Huffington’s Distinguished University Chair, Professor of Neurology and Director of George and Cynthia Mitchell Center for Alzheimer’s Disease and Related Brain Disorders at The University of Texas Medical School in Houston.
Daniel A. Heller, PhD & Kara Long Roche, MD
Project Title: “Clinical Development of an Implantable Nanosensor for Early-Stage Ovarian Cancer Detection”
Dr. Heller is head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering. Dr. Long Roche is a gynecologic oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Long Roche and Dr. Heller are Co-Principal Investigators on this project.
Many thanks to Douglas A. Levine, MD, of NYU Perlmutter Cancer Center, for his contributions as Co-PI during the first phase of this project.
Samuel C. Mok, PhD
Project Title: “Identification of ovarian cancer biomarkers in women at high risk of developing ovarian cancer using emerging EFIRM Liquid Biopsy (eLB) technology”
Dr. Mok holds the Stephanie C. Stelter Professorship in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center.
Ronny Drapkin, MD, PhD & Jarrod Marto, PhD
Project Title: “Biomarker Discovery and Validation in Tissue Proximal Fluids”
Dr. Drapkin is an Associate Professor of Obstetrics, Gynecology and Pathology at the University of Pennsylvania and the Director of the Ovarian Cancer Research Center at Penn Medicine. Dr. Marto is an Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Director of the Blais Proteomics Center and Principal Investigator for the Department of Cancer Biology at Dana-Farber Cancer Institute. Dr. Drapkin and Dr. Marto are Co-Principal Investigators on this project.
Abhijit Patel, MD, PhD & Alessandro Santin, MD
Project Title: “Integrated Analysis of Proteomic and Genomic Signatures in Blood for Early Detection of Ovarian Cancer”
Dr. Patel is an Associate Professor of Therapeutic Radiology at Yale Cancer Center. Dr. Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences, the Disease Aligned Research Team Leader, Gynecologic Oncology Program, and Co-Chief, Section of Gynecologic Oncology at Yale Cancer Center. Dr. Patel and Dr. Santin are Co-Principal Investigators on this project.
Rising Star Grant, Kevin Elias, MD
Project Title: “A murine model for early ovarian cancer detection using circulating microRNA”
Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women's Hospital.
Rising Star Grant, Maria Sol Recouvreux , PhD
Project Title: “The Role of Ciliated Cells in Preventing Fallopian Tube Cancer Initiation”
Dr. Recouvreux is a postdoctoral fellow at the David Geffen School of Medicine at the University of California, Los Angeles.
Rising Star Grant, Sarah Hill, MD, PhD
Project Title: “Deciphering the mechanisms and relevance of replication stress in ovarian cancer precursor cells”
Dr. Hill is a gynecologic pathologist and an independent investigator at Dana-Farber Cancer Institute.
Consortium Grant, Ronny Drapkin, MD, PhD, Daniel Heller, PhD, Ie-Ming Shih, MD, PhD, Rugang Zhang, PhD
Project Title: “Integration of Advanced Genomic and Bioengineering Approaches for Early Detection and Prevention of Ovarian Cancer”
Tina's Wish is honored to present its second Consortium Grant to this cutting edge team of researchers who will collaborate together for the next three years.
#1
deadliest gynecologic
cancer
80%
of women are diagnosed
at an advanced stage
27%
of women have a 5-year
survival rate after an
advanced stage diagnosis